Sonoporation: Applications for Cancer Therapy

  • Jiale Qin
  • Tzu-Yin Wang
  • Jürgen K. WillmannEmail author
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 880)


Therapeutic efficacy of both traditional chemotherapy and gene therapy in cancer is highly dependent on the ability to deliver drugs across natural barriers, such as the vessel wall or tumor cell membranes. In this regard, sonoporation induced by ultrasound-guided microbubble (USMB) destruction has been widely investigated in the enhancement of therapeutic drug delivery given it can help overcome these natural barriers, thereby increasing drug delivery into cancer. In this chapter we discuss challenges in current cancer therapy and how some of these challenges could be overcome using USMB-mediated drug delivery. We particularly focus on recent advances in delivery approaches that have been developed to further improve therapeutic efficiency and specificity of various cancer treatments. An example of clinical translation of USMB-mediated drug delivery is also shown.


Sonoporation Drug delivery Cancer 


  1. Apfel RE, Holland CK (1991) Gauging the likelihood of cavitation from short-pulse, low-duty cycle diagnostic ultrasound. Ultrasound Med Biol 17:179–185PubMedCrossRefGoogle Scholar
  2. Bachawal SV, Jensen KC, Lutz AM, Gambhir SS, Tranquart F, Tian L, Willmann JK (2013) Earlier detection of breast cancer with ultrasound molecular imaging in a transgenic mouse model. Cancer Res 73:1689–1698PubMedCentralPubMedCrossRefGoogle Scholar
  3. Bae YH (2009) Drug targeting and tumor heterogeneity. J Control Release 133:2–3PubMedCentralPubMedCrossRefGoogle Scholar
  4. Bekeredjian R, Kroll RD, Fein E, Tinkov S, Coester C, Winter G, Katus HA, Kulaksiz H (2007) Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. Ultrasound Med Biol 33:1592–1598PubMedCrossRefGoogle Scholar
  5. Bohmer MR, Chlon CH, Raju BI, Chin CT, Shevchenko T, Klibanov AL (2010) Focused ultrasound and microbubbles for enhanced extravasation. J Control Release 148:18–24PubMedCentralPubMedCrossRefGoogle Scholar
  6. Borden MA, Caskey CF, Little E, Gillies RJ, Ferrara KW (2007) DNA and polylysine adsorption and multilayer construction onto cationic lipid-coated microbubbles. Langmuir 23:9401–9408PubMedCrossRefGoogle Scholar
  7. Boucher Y, Baxter LT, Jain RK (1990) Interstitial pressure gradients in tissue-isolated and subcutaneous tumors: implications for therapy. Cancer Res 50:4478–4484PubMedGoogle Scholar
  8. Brayman AA, Coppage ML, Vaidya S, Miller MW (1999) Transient poration and cell surface receptor removal from human lymphocytes in-vitro by 1 MHz ultrasound. Ultrasound Med Biol 25:999–1008PubMedCrossRefGoogle Scholar
  9. Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, Karaca G, Troester MA, Tse CK, Edmiston S, Deming SL, Geradts J, Cheang MC, Nielsen TO, Moorman PG, Earp HS, Millikan RC (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492–2502PubMedCrossRefGoogle Scholar
  10. Carlisle R, Choi J, Bazan-Peregrino M, Laga R, Subr V, Kostka L, Ulbrich K, Coussios CC, Seymour LW (2013) Enhanced tumor uptake and penetration of virotherapy using polymer stealthing and focused ultrasound. J Natl Cancer Inst 105:1701–1710PubMedCentralPubMedCrossRefGoogle Scholar
  11. Carson AR, McTiernan CF, Lavery L, Grata M, Leng X, Wang J, Chen X, Villanueva FS (2012) Ultrasound-targeted microbubble destruction to deliver siRNA cancer therapy. Cancer Res 72:6191–6199PubMedCentralPubMedCrossRefGoogle Scholar
  12. Caskey CF, Stieger SM, Qin S, Dayton PA, Ferrara KW (2007) Direct observations of ultrasound microbubble contrast agent interaction with the microvessel wall. J Acoust Soc Am 122:1191–1200PubMedCrossRefGoogle Scholar
  13. Chen H, Kreider W, Brayman AA, Bailey MR, Matula TJ (2011) Blood vessel deformations on microsecond time scales by ultrasonic cavitation. Phys Rev Lett 106:034301PubMedCentralPubMedCrossRefGoogle Scholar
  14. Chiang CL, Benencia F, Coukos G (2010) Whole tumor antigen vaccines. Semin Immunol 22:132–143PubMedCentralPubMedCrossRefGoogle Scholar
  15. Chuang YH, Wang YH, Chang TK, Lin CJ, Li PC (2014) Albumin acts like transforming growth factor beta1 in microbubble-based drug delivery. Ultrasound Med Biol 40:765–774PubMedCrossRefGoogle Scholar
  16. Cochran MC, Eisenbrey J, Ouma RO, Soulen M, Wheatley MA (2011a) Doxorubicin and paclitaxel loaded microbubbles for ultrasound triggered drug delivery. Int J Pharm 414:161–170PubMedCentralPubMedCrossRefGoogle Scholar
  17. Cochran MC, Eisenbrey JR, Soulen MC, Schultz SM, Ouma RO, White SB, Furth EE, Wheatley MA (2011b) Disposition of ultrasound sensitive polymeric drug carrier in a rat hepatocellular carcinoma model. Acad Radiol 18:1341–1348PubMedCentralPubMedCrossRefGoogle Scholar
  18. Davies Cde L, Lundstrom LM, Frengen J, Eikenes L, Bruland SO, Kaalhus O, Hjelstuen MH, Brekken C (2004) Radiation improves the distribution and uptake of liposomal doxorubicin (caelyx) in human osteosarcoma xenografts. Cancer Res 64:547–553PubMedCrossRefGoogle Scholar
  19. De Temmerman ML, Dewitte H, Vandenbroucke RE, Lucas B, Libert C, Demeester J, De Smedt SC, Lentacker I, Rejman J (2011) mRNA-Lipoplex loaded microbubble contrast agents for ultrasound-assisted transfection of dendritic cells. Biomaterials 32:9128–9135PubMedCrossRefGoogle Scholar
  20. Deng Z, Yan F, Jin Q, Li F, Wu J, Liu X, Zheng H (2014) Reversal of multidrug resistance phenotype in human breast cancer cells using doxorubicin-liposome-microbubble complexes assisted by ultrasound. J Control Release 174:109–116PubMedCrossRefGoogle Scholar
  21. Deshpande N, Needles A, Willmann JK (2010) Molecular ultrasound imaging: current status and future directions. Clin Radiol 65:567–581PubMedCentralPubMedCrossRefGoogle Scholar
  22. Dubinsky TJ, Cuevas C, Dighe MK, Kolokythas O, Hwang JH (2008) High-intensity focused ultrasound: current potential and oncologic applications. Am J Roentgenol 190:191–199CrossRefGoogle Scholar
  23. Ducreux M, Rougier P, Fandi A, Clavero-Fabri MC, Villing AL, Fassone F, Fandi L, Zarba J, Armand JP (1998) Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol 9:653–656PubMedCrossRefGoogle Scholar
  24. Duvshani-Eshet M, Benny O, Morgenstern A, Machluf M (2007) Therapeutic ultrasound facilitates antiangiogenic gene delivery and inhibits prostate tumor growth. Mol Cancer Ther 6:2371–2382PubMedCrossRefGoogle Scholar
  25. Edelstein ML, Abedi MR, Wixon J (2007) Gene therapy clinical trials worldwide to 2007--an update. J Gene Med 9:833–842PubMedCrossRefGoogle Scholar
  26. Eggen S, Afadzi M, Nilssen EA, Haugstad SB, Angelsen B, Davies Cde L (2013) Ultrasound improves the uptake and distribution of liposomal Doxorubicin in prostate cancer xenografts. Ultrasound Med Biol 39:1255–1266PubMedCrossRefGoogle Scholar
  27. Eggen S, Fagerland SM, Morch Y, Hansen R, Sovik K, Berg S, Furu H, Bohn AD, Lilledahl MB, Angelsen A, Angelsen B, de Lange DC (2014) Ultrasound-enhanced drug delivery in prostate cancer xenografts by nanoparticles stabilizing microbubbles. J Control Release 187:39–49PubMedCrossRefGoogle Scholar
  28. Eikenes L, Bruland OS, Brekken C, Davies Cde L (2004) Collagenase increases the transcapillary pressure gradient and improves the uptake and distribution of monoclonal antibodies in human osteosarcoma xenografts. Cancer Res 64:4768–4773PubMedCrossRefGoogle Scholar
  29. Elodie Debefve YW, Krueger T, van den Bergh H (2013) Photodynamic therapy for increased delivery of anticancer drugs. In: Handbook of photomedicine. CRC Press, FloridaGoogle Scholar
  30. Fan Z, Liu H, Mayer M, Deng CX (2012) Spatiotemporally controlled single cell sonoporation. Proc Natl Acad Sci U S A 109:16486–16491PubMedCentralPubMedCrossRefGoogle Scholar
  31. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F (2014) Cancer worldwide. In: Stewart BW, Wild CP (eds) World cancer report 2014, vol 3. International Agency for Research on Cancer (IARC), Lyon, pp 16–80Google Scholar
  32. Foygel K, Wang H, Machtaler S, Lutz AM, Chen R, Pysz M, Lowe AW, Tian L, Carrigan T, Brentnall TA, Willmann JK (2013) Detection of pancreatic ductal adenocarcinoma in mice by ultrasound imaging of thymocyte differentiation antigen 1. Gastroenterology 4:885–894CrossRefGoogle Scholar
  33. Fujii H, Matkar P, Liao C, Rudenko D, Lee PJ, Kuliszewski MA, Prud’homme GJ, Leong-Poi H (2013) Optimization of ultrasound-mediated anti-angiogenic cancer gene therapy. Mol Ther Nucleic Acids 2, e94PubMedCrossRefGoogle Scholar
  34. Fukumura D, Jain RK (2007) Tumor microenvironment abnormalities: causes, consequences, and strategies to normalize. J Cell Biochem 101:937–949PubMedCrossRefGoogle Scholar
  35. Ghoshal G, Swat S, Oelze ML (2012) Synergistic effects of ultrasound-activated microbubbles and doxorubicin on short-term survival of mouse mammary tumor cells. Ultrason Imaging 34:15–22PubMedCentralPubMedCrossRefGoogle Scholar
  36. Goertz DE, Todorova M, Mortazavi O, Agache V, Chen B, Karshafian R, Hynynen K (2012) Antitumor effects of combining docetaxel (taxotere) with the antivascular action of ultrasound stimulated microbubbles. PLoS One 7, e52307PubMedCentralPubMedCrossRefGoogle Scholar
  37. Gottesman MM (2002) Mechanisms of cancer drug resistance. Annu Rev Med 53:615–627PubMedCrossRefGoogle Scholar
  38. Greco A, Di Benedetto A, Howard CM, Kelly S, Nande R, Dementieva Y, Miranda M, Brunetti A, Salvatore M, Claudio L, Sarkar D, Dent P, Curiel DT, Fisher PB, Claudio PP (2010) Eradication of therapy-resistant human prostate tumors using an ultrasound-guided site-specific cancer terminator virus delivery approach. Mol Ther 18:295–306PubMedCentralPubMedCrossRefGoogle Scholar
  39. Grossman R, Tyler B, Hwang L, Zadnik P, Lal B, Javaherian K, Brem H (2011) Improvement in the standard treatment for experimental glioma by fusing antibody Fc domain to endostatin. J Neurosurg 115:1139–1146PubMedCrossRefGoogle Scholar
  40. Guarneri V, Dieci MV, Conte P (2012) Enhancing intracellular taxane delivery: current role and perspectives of nanoparticle albumin-bound paclitaxel in the treatment of advanced breast cancer. Expert Opin Pharmacother 13:395–406PubMedCrossRefGoogle Scholar
  41. Haag P, Frauscher F, Gradl J, Seitz A, Schafer G, Lindner JR, Klibanov AL, Bartsch G, Klocker H, Eder IE (2006) Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J Steroid Biochem Mol Biol 102:103–113PubMedCrossRefGoogle Scholar
  42. Hauser J, Hauser M, Muhr G, Esenwein S (2009) Ultrasound-induced modifications of cytoskeletal components in osteoblast-like SAOS-2 cells. J Orthop Res 27:286–294PubMedCrossRefGoogle Scholar
  43. Heath CH, Sorace A, Knowles J, Rosenthal E, Hoyt K (2012) Microbubble therapy enhances anti-tumor properties of cisplatin and cetuximab in-vitro and in-vivo. Otolaryngol Head Neck Surg 146:938–945PubMedCentralPubMedCrossRefGoogle Scholar
  44. Helse Bergen H, Georg D (2010) Treatment of pancreatic adenocarcinoma by combining contrast agent and gemcitabine under sonication. Helse Bergen HF, Haukeland Unversity Hospital, BergenGoogle Scholar
  45. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, Jain RK (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci U S A 95:4607–4612PubMedCentralPubMedCrossRefGoogle Scholar
  46. Hoffmann A, Bredno J, Wendland M, Derugin N, Ohara P, Wintermark M (2011) High and low molecular weight fluorescein isothiocyanate (FITC)-dextrans to assess blood-brain barrier disruption: technical considerations. Transl Stroke Res 2:106–111PubMedCentralPubMedCrossRefGoogle Scholar
  47. Iwanaga K, Tominaga K, Yamamoto K, Habu M, Maeda H, Akifusa S, Tsujisawa T, Okinaga T, Fukuda J, Nishihara T (2007) Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther 14:354–363PubMedCrossRefGoogle Scholar
  48. Jain RK (1998) Delivery of molecular and cellular medicine to solid tumors. J Control Release 53:49–67PubMedCrossRefGoogle Scholar
  49. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 6:69–90CrossRefGoogle Scholar
  50. Juffermans LJ, Meijering BD, Henning RH, Deelman LE (2014) Ultrasound and microbubble-targeted delivery of small interfering RNA into primary endothelial cells is more effective than delivery of plasmid DNA. Ultrasound Med Biol 40:532–540PubMedCrossRefGoogle Scholar
  51. Kaneko OF, Willmann JK (2012) Ultrasound for molecular imaging and therapy in cancer. Quant Imaging Med Surg 2:87–97PubMedCentralPubMedGoogle Scholar
  52. Kiessling F, Fokong S, Koczera P, Lederle W, Lammers T (2012) Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med 53:345–348PubMedCrossRefGoogle Scholar
  53. Kircher MF, Willmann JK (2012a) Molecular body imaging: MR imaging, CT, and US. Part I. Principles. Radiology 263:633–643PubMedCentralPubMedCrossRefGoogle Scholar
  54. Kircher MF, Willmann JK (2012b) Molecular body imaging: MR imaging, CT, and US. Part II. Applications. Radiology 264:349–368PubMedCrossRefGoogle Scholar
  55. Kisker O, Becker CM, Prox D, Fannon M, D’Amato R, Flynn E, Fogler WE, Sim BK, Allred EN, Pirie-Shepherd SR, Folkman J (2001) Continuous administration of endostatin by intraperitoneally implanted osmotic pump improves the efficacy and potency of therapy in a mouse xenograft tumor model. Cancer Res 61:7669–7674PubMedGoogle Scholar
  56. Kohane DS, Tse JY, Yeo Y, Padera R, Shubina M, Langer R (2006) Biodegradable polymeric microspheres and nanospheres for drug delivery in the peritoneum. J Biomed Mater Res A 77:351–361PubMedCrossRefGoogle Scholar
  57. Kotopoulis S, Dimcevski G, Gilja OH, Hoem D, Postema M (2013) Treatment of human pancreatic cancer using combined ultrasound, microbubbles, and gemcitabine: a clinical case study. Med Phys 40:072902PubMedCrossRefGoogle Scholar
  58. Kotopoulis S, Delalande A, Popa M, Mamaeva V, Dimcevski G, Gilja OH, Postema M, Gjertsen BT, McCormack E (2014) Sonoporation-enhanced chemotherapy significantly reduces primary tumour burden in an orthotopic pancreatic cancer xenograft. Mol Imaging Biol 16:53–62PubMedCrossRefGoogle Scholar
  59. Kun Y, Lin S (2014) Safety study of combining ultrasound microbubbles and chemotherapy to treat malignant neoplasms of liver metastases from gastrointestinal tumors and pancreatic carcinoma. Beijing Cancer Hospital, BeijingGoogle Scholar
  60. Leslie TA, Kennedy JE (2006) High-intensity focused ultrasound principles, current uses, and potential for the future. Ultrasound Q 22:263–272PubMedCrossRefGoogle Scholar
  61. Liao ZK, Tsai KC, Wang HT, Tseng SH, Deng WP, Chen WS, Hwang LH (2012) Sonoporation-mediated anti-angiogenic gene transfer into muscle effectively regresses distant orthotopic tumors. Cancer Gene Ther 19:171–180PubMedCrossRefGoogle Scholar
  62. Liu HL, Hua MY, Chen PY, Chu PC, Pan CH, Yang HW, Huang CY, Wang JJ, Yen TC, Wei KC (2010) Blood-brain barrier disruption with focused ultrasound enhances delivery of chemotherapeutic drugs for glioblastoma treatment. Radiology 255:415–425PubMedCrossRefGoogle Scholar
  63. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, Burney P, Carapetis J, Chen H, Chou D, Chugh SS, Coffeng LE, Colan SD, Colquhoun S, Colson KE, Condon J, Connor MD, Cooper LT, Corriere M, Cortinovis M, de Vaccaro KC, Couser W, Cowie BC, Criqui MH, Cross M, Dabhadkar KC, Dahodwala N, De Leo D, Degenhardt L, Delossantos A, Denenberg J, Des Jarlais DC, Dharmaratne SD, Dorsey ER, Driscoll T, Duber H, Ebel B, Erwin PJ, Espindola P, Ezzati M, Feigin V, Flaxman AD, Forouzanfar MH, Fowkes FG, Franklin R, Fransen M, Freeman MK, Gabriel SE, Gakidou E, Gaspari F, Gillum RF, Gonzalez-Medina D, Halasa YA, Haring D, Harrison JE, Havmoeller R, Hay RJ, Hoen B, Hotez PJ, Hoy D, Jacobsen KH, James SL, Jasrasaria R, Jayaraman S, Johns N, Karthikeyan G, Kassebaum N, Keren A, Khoo JP, Knowlton LM, Kobusingye O, Koranteng A, Krishnamurthi R, Lipnick M, Lipshultz SE, Ohno SL, Mabweijano J, MacIntyre MF, Mallinger L, March L, Marks GB, Marks R, Matsumori A, Matzopoulos R, Mayosi BM, McAnulty JH, McDermott MM, McGrath J, Mensah GA, Merriman TR, Michaud C, Miller M, Miller TR, Mock C, Mocumbi AO, Mokdad AA, Moran A, Mulholland K, Nair MN, Naldi L, Narayan KM, Nasseri K, Norman P, O’Donnell M, Omer SB, Ortblad K, Osborne R, Ozgediz D, Pahari B, Pandian JD, Rivero AP, Padilla RP, Perez-Ruiz F, Perico N, Phillips D, Pierce K, Pope CA 3rd, Porrini E, Pourmalek F, Raju M, Ranganathan D, Rehm JT, Rein DB, Remuzzi G, Rivara FP, Roberts T, De Leon FR, Rosenfeld LC, Rushton L, Sacco RL, Salomon JA, Sampson U, Sanman E, Schwebel DC, Segui-Gomez M, Shepard DS, Singh D, Singleton J, Sliwa K, Smith E, Steer A, Taylor JA, Thomas B, Tleyjeh IM, Towbin JA, Truelsen T, Undurraga EA, Venketasubramanian N, Vijayakumar L, Vos T, Wagner GR, Wang M, Wang W, Watt K, Weinstock MA, Weintraub R, Wilkinson JD, Woolf AD, Wulf S, Yeh PH, Yip P, Zabetian A, Zheng ZJ, Lopez AD, Murray CJ, AlMazroa MA, Memish ZA (2012) Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380:2095–2128PubMedCrossRefGoogle Scholar
  64. Lutz AM, Bachawal SV, Drescher CW, Pysz MA, Willmann JK, Gambhir SS (2014) Ultrasound molecular imaging in a human CD276 expression-modulated murine ovarian cancer model. Clin Cancer Res 5:1313–1322CrossRefGoogle Scholar
  65. Markman M, Rowinsky E, Hakes T, Reichman B, Jones W, Lewis JL Jr, Rubin S, Curtin J, Barakat R, Phillips M et al (1992) Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study. J Clin Oncol 10:1485–1491PubMedGoogle Scholar
  66. Matsuo M, Yamaguchi K, Feril LB Jr, Endo H, Ogawa K, Tachibana K, Nakayama J (2011) Synergistic inhibition of malignant melanoma proliferation by melphalan combined with ultrasound and microbubbles. Ultrason Sonochem 18:1218–1224PubMedCrossRefGoogle Scholar
  67. Meijering BD, Juffermans LJ, van Wamel A, Henning RH, Zuhorn IS, Emmer M, Versteilen AM, Paulus WJ, van Gilst WH, Kooiman K, de Jong N, Musters RJ, Deelman LE, Kamp O (2009) Ultrasound and microbubble-targeted delivery of macromolecules is regulated by induction of endocytosis and pore formation. Circ Res 104:679–687PubMedCrossRefGoogle Scholar
  68. Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6:583–592PubMedCrossRefGoogle Scholar
  69. Molema G, Meijer DK, de Leij LF (1998) Tumor vasculature targeted therapies: getting the players organized. Biochem Pharmacol 55:1939–1945PubMedCrossRefGoogle Scholar
  70. Mow VC, Mak AF, Lai WM, Rosenberg LC, Tang LH (1984) Viscoelastic properties of proteoglycan subunits and aggregates in varying solution concentrations. J Biomech 17:325–338PubMedCrossRefGoogle Scholar
  71. Newman CM, Bettinger T (2007) Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther 14:465–475PubMedCrossRefGoogle Scholar
  72. Nie F, Xu HX, Lu MD, Wang Y, Tang Q (2008) Anti-angiogenic gene therapy for hepatocellular carcinoma mediated by microbubble-enhanced ultrasound exposure: an in-vivo experimental study. J Drug Target 16:389–395PubMedCrossRefGoogle Scholar
  73. O’Brien WD Jr (2007) Ultrasound-biophysics mechanisms. Prog Biophys Mol Biol 93:212–255PubMedCentralPubMedCrossRefGoogle Scholar
  74. Oda Y, Suzuki R, Otake S, Nishiie N, Hirata K, Koshima R, Nomura T, Utoguchi N, Kudo N, Tachibana K, Maruyama K (2012) Prophylactic immunization with Bubble liposomes and ultrasound-treated dendritic cells provided a four-fold decrease in the frequency of melanoma lung metastasis. J Control Release 160:362–366PubMedCrossRefGoogle Scholar
  75. Panje CM, Wang DS, Pysz MA, Paulmurugan R, Ren Y, Tranquart F, Tian L, Willmann JK (2012) Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in-vivo transfection efficiency. Theranostics 2:1078–1091PubMedCentralPubMedCrossRefGoogle Scholar
  76. Panje CM, Wang DS, Willmann JK (2013) Ultrasound and microbubble-mediated gene delivery in cancer: progress and perspectives. Invest Radiol 48:755–769PubMedCrossRefGoogle Scholar
  77. Paproski RJ, Yao SY, Favis N, Evans D, Young JD, Cass CE, Zemp RJ (2013) Human concentrative nucleoside transporter 3 transfection with ultrasound and microbubbles in nucleoside transport deficient HEK293 cells greatly increases gemcitabine uptake. PLoS One 8, e56423PubMedCentralPubMedCrossRefGoogle Scholar
  78. Park J, Zhang Y, Vykhodtseva N, Akula JD, McDannold NJ (2012a) Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles. PLoS One 7, e42754PubMedCentralPubMedCrossRefGoogle Scholar
  79. Park EJ, Zhang YZ, Vykhodtseva N, McDannold N (2012b) Ultrasound-mediated blood-brain/blood-tumor barrier disruption improves outcomes with trastuzumab in a breast cancer brain metastasis model. J Control Release 163:277–284PubMedCentralPubMedCrossRefGoogle Scholar
  80. Parvizi J, Parpura V, Greenleaf JF, Bolander ME (2002) Calcium signaling is required for ultrasound-stimulated aggrecan synthesis by rat chondrocytes. J Orthop Res 20:51–57PubMedCrossRefGoogle Scholar
  81. Patil AV, Rychak JJ, Klibanov AL, Hossack JA (2011) Real-time technique for improving molecular imaging and guiding drug delivery in large blood vessels: in-vitro and ex vivo results. Mol Imaging 10:238–247PubMedCentralPubMedGoogle Scholar
  82. Pu C, Chang S, Sun J, Zhu S, Liu H, Zhu Y, Wang Z, Xu RX (2014) Ultrasound-mediated destruction of LHRHa-targeted and paclitaxel-loaded lipid microbubbles for the treatment of intraperitoneal ovarian cancer xenografts. Mol Pharm 11:49–58PubMedCentralPubMedCrossRefGoogle Scholar
  83. Pysz MA, Willmann JK (2011) Targeted contrast-enhanced ultrasound: an emerging technology in abdominal and pelvic imaging. Gastroenterology 140:785–790PubMedCentralPubMedCrossRefGoogle Scholar
  84. Qin S, Caskey CF, Ferrara KW (2009) Ultrasound contrast microbubbles in imaging and therapy: physical principles and engineering. Phys Med Biol 54:R27–R57PubMedCentralPubMedCrossRefGoogle Scholar
  85. Rahman AM, Yusuf SW, Ewer MS (2007) Anthracycline-induced cardiotoxicity and the cardiac-sparing effect of liposomal formulation. Int J Nanomed 2:567–583Google Scholar
  86. Schlicher RK, Radhakrishna H, Tolentino TP, Apkarian RP, Zarnitsyn V, Prausnitz MR (2006) Mechanism of intracellular delivery by acoustic cavitation. Ultrasound Med Biol 32:915–924PubMedCrossRefGoogle Scholar
  87. Schneider M (2008) Molecular imaging and ultrasound-assisted drug delivery. J Endourol 22:795–802PubMedCrossRefGoogle Scholar
  88. Sever A, Jones S, Cox K, Weeks J, Mills P, Jones P (2009) Preoperative localization of sentinel lymph nodes using intradermal microbubbles and contrast-enhanced ultrasonography in patients with breast cancer. Br J Surg 96:1295–1299PubMedCrossRefGoogle Scholar
  89. Sheikov N, McDannold N, Sharma S, Hynynen K (2008) Effect of focused ultrasound applied with an ultrasound contrast agent on the tight junctional integrity of the brain microvascular endothelium. Ultrasound Med Biol 34:1093–1104PubMedCentralPubMedCrossRefGoogle Scholar
  90. Shillitoe EJ (2009) Gene therapy: the end of the rainbow? Head Neck Oncol 1:7PubMedCentralPubMedCrossRefGoogle Scholar
  91. Sirsi SR, Borden MA (2014) State-of-the-art materials for ultrasound-triggered drug delivery. Adv Drug Deliv Rev 72:3–14PubMedCrossRefGoogle Scholar
  92. Sonoda S, Tachibana K, Uchino E, Yamashita T, Sakoda K, Sonoda KH, Hisatomi T, Izumi Y, Sakamoto T (2007) Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilization. Cancer Biol Ther 6:1276–1283PubMedCrossRefGoogle Scholar
  93. Sorace AG, Warram JM, Umphrey H, Hoyt K (2012) Microbubble-mediated ultrasonic techniques for improved chemotherapeutic delivery in cancer. J Drug Target 20:43–54PubMedCentralPubMedCrossRefGoogle Scholar
  94. Sorace AG, Korb M, Warram JM, Umphrey H, Zinn KR, Rosenthal E, Hoyt K (2014) Ultrasound-stimulated drug delivery for treatment of residual disease after incomplete resection of head and neck cancer. Ultrasound Med Biol 40:755–764PubMedCentralPubMedCrossRefGoogle Scholar
  95. Suzuki R, Namai E, Oda Y, Nishiie N, Otake S, Koshima R, Hirata K, Taira Y, Utoguchi N, Negishi Y, Nakagawa S, Maruyama K (2010) Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J Control Release 142:245–250PubMedCrossRefGoogle Scholar
  96. Szakacs G, Paterson JK, Ludwig JA, Booth-Genthe C, Gottesman MM (2006) Targeting multidrug resistance in cancer. Nat Rev Drug Discov 5:219–234PubMedCrossRefGoogle Scholar
  97. Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N, Aoki M, Ogihara T, Yasufumi K, Morishita R (2002) Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 105:1233–1239PubMedCrossRefGoogle Scholar
  98. Timmerman JM, Levy R (1999) Dendritic cell vaccines for cancer immunotherapy. Annu Rev Med 50:507–529PubMedCrossRefGoogle Scholar
  99. Ting CY, Fan CH, Liu HL, Huang CY, Hsieh HY, Yen TC, Wei KC, Yeh CK (2012) Concurrent blood-brain barrier opening and local drug delivery using drug-carrying microbubbles and focused ultrasound for brain glioma treatment. Biomaterials 33:704–712PubMedCrossRefGoogle Scholar
  100. Todorova M, Agache V, Mortazavi O, Chen B, Karshafian R, Hynynen K, Man S, Kerbel RS, Goertz DE (2013) Antitumor effects of combining metronomic chemotherapy with the antivascular action of ultrasound stimulated microbubbles. Int J Cancer 132:2956–2966PubMedCrossRefGoogle Scholar
  101. Tong AW, Jay CM, Senzer N, Maples PB, Nemunaitis J (2009) Systemic therapeutic gene delivery for cancer: crafting Paris’ arrow. Curr Gene Ther 9:45–60PubMedCrossRefGoogle Scholar
  102. Treat LH, McDannold N, Zhang Y, Vykhodtseva N, Hynynen K (2012) Improved anti-tumor effect of liposomal doxorubicin after targeted blood-brain barrier disruption by MRI-guided focused ultrasound in rat glioma. Ultrasound Med Biol 38:1716–1725PubMedCentralPubMedCrossRefGoogle Scholar
  103. Tsai M, Lu Z, Wang J, Yeh TK, Wientjes MG, Au JL (2007) Effects of carrier on disposition and antitumor activity of intraperitoneal Paclitaxel. Pharm Res 24:1691–1701PubMedCentralPubMedCrossRefGoogle Scholar
  104. Tzu-Yin W, Wilson KE, Machtaler S, Willmann JK (2014) Ultrasound and microbubble guided drug delivery: mechanistic understanding and clinical implications. Curr Pharm Biotechnol 14:743–752CrossRefGoogle Scholar
  105. van Wamel A, Bouakaz A, Versluis M, de Jong N (2004) Micromanipulation of endothelial cells: ultrasound-microbubble-cell interaction. Ultrasound Med Biol 30:1255–1258PubMedCrossRefGoogle Scholar
  106. van Wamel A, Kooiman K, Emmer M, ten Cate FJ, Versluis M, de Jong N (2006) Ultrasound microbubble induced endothelial cell permeability. J Control Release 116:e100–e102PubMedCrossRefGoogle Scholar
  107. Waite CL, Roth CM (2012) Nanoscale drug delivery systems for enhanced drug penetration into solid tumors: current progress and opportunities. Crit Rev Biomed Eng 40:21–41PubMedCentralPubMedCrossRefGoogle Scholar
  108. Wang Y, Yuan F (2006) Delivery of viral vectors to tumor cells: extracellular transport, systemic distribution, and strategies for improvement. Ann Biomed Eng 34:114–127PubMedCrossRefGoogle Scholar
  109. Wang DS, Panje C, Pysz MA, Paulmurugan R, Rosenberg J, Gambhir SS, Schneider M, Willmann JK (2012) Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology 264:721–732PubMedCentralPubMedCrossRefGoogle Scholar
  110. Wang XL, Zhao XY, Li S, Jia CJ, Jiang L, Shi TM, Ren WD (2013a) A novel plasmid and SonoVue formulation plus ultrasound sonication for effective gene delivery in nude mice. Life Sci 93:536–542PubMedCrossRefGoogle Scholar
  111. Wang Y, Bai WK, Shen E, Hu B (2013b) Sonoporation by low-frequency and low-power ultrasound enhances chemotherapeutic efficacy in prostate cancer cells. Oncol Lett 6:495–498PubMedCentralPubMedGoogle Scholar
  112. Ward M, Wu J, Chiu JF (2000) Experimental study of the effects of optison concentration on sonoporation in-vitro. Ultrasound Med Biol 26:1169–1175PubMedCrossRefGoogle Scholar
  113. Willmann JK, van Bruggen N, Dinkelborg LM, Gambhir SS (2008) Molecular imaging in drug development. Nat Rev Drug Discov 7:591–607PubMedCrossRefGoogle Scholar
  114. Wilson KE, Wang TY, Willmann JK (2013) Acoustic and photoacoustic molecular imaging of cancer. J Nucl Med 54:1851–1854PubMedCentralPubMedCrossRefGoogle Scholar
  115. Wood AK, Bunte RM, Price HE, Deitz MS, Tsai JH, Lee WM, Sehgal CM (2008) The disruption of murine tumor neovasculature by low-intensity ultrasound-comparison between 1- and 3-MHz sonication frequencies. Acad Radiol 15:1133–1141PubMedCentralPubMedCrossRefGoogle Scholar
  116. Xing W, Gang WZ, Yong Z, Yi ZY, Shan XC, Tao RH (2008) Treatment of xenografted ovarian carcinoma using paclitaxel-loaded ultrasound microbubbles. Acad Radiol 15:1574–1579PubMedCrossRefGoogle Scholar
  117. Yamaguchi K, Feril LB Jr, Tachibana K, Takahashi A, Matsuo M, Endo H, Harada Y, Nakayama J (2011) Ultrasound-mediated interferon beta gene transfection inhibits growth of malignant melanoma. Biochem Biophys Res Commun 411:137–142PubMedCrossRefGoogle Scholar
  118. Yan F, Li L, Deng Z, Jin Q, Chen J, Yang W, Yeh CK, Wu J, Shandas R, Liu X, Zheng H (2013) Paclitaxel-liposome-microbubble complexes as ultrasound-triggered therapeutic drug delivery carriers. J Control Release 166(3):246–255PubMedCrossRefGoogle Scholar
  119. Yu BF, Wu J, Zhang Y, Sung HW, Xie J, Li RK (2013) Ultrasound-targeted HSVtk and Timp3 gene delivery for synergistically enhanced antitumor effects in hepatoma. Cancer Gene Ther 20:290–297PubMedCrossRefGoogle Scholar
  120. Zhang JZ, Saggar JK, Zhou ZL, Hu B (2012) Different effects of sonoporation on cell morphology and viability. Bosn J Basic Med Sci 12:64–68PubMedCentralPubMedGoogle Scholar
  121. Zhao YZ, Dai DD, Lu CT, Lv HF, Zhang Y, Li X, Li WF, Wu Y, Jiang L, Li XK, Huang PT, Chen LJ, Lin M (2012) Using acoustic cavitation to enhance chemotherapy of DOX liposomes: experiment in-vitro and in-vivo. Drug Dev Ind Pharm 38:1090–1098PubMedCrossRefGoogle Scholar
  122. Zhou S, Li S, Liu Z, Tang Y, Wang Z, Gong J, Liu C (2010) Ultrasound-targeted microbubble destruction mediated herpes simplex virus-thymidine kinase gene treats hepatoma in mice. J Exp Clin Cancer Res 29:170PubMedCentralPubMedCrossRefGoogle Scholar
  123. Zimm S, Cleary SM, Lucas WE, Weiss RJ, Markman M, Andrews PA, Schiefer MA, Kim S, Horton C, Howell SB (1987) Phase I/pharmacokinetic study of intraperitoneal cisplatin and etoposide. Cancer Res 47:1712–1716PubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2016

Authors and Affiliations

  1. 1.Department of Radiology, Molecular Imaging Program at StanfordStanford University, School of MedicineStanfordUSA

Personalised recommendations